Clinical Trial

Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure

Study acronym: Heart-eXg
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life. Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control) or the Heart-Exergame (Heart-eXg) intervention for a period of 3 months. Patients randomised to the Heart-eXg group will receive an exergame with feedback and tailoring to adapt the exergaming advice. Patients will also be able to play with a person in their own network.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-12-06; most recent amendment 2026-03-09.
Trial Details
NCT Number NCT05641662
Lead Sponsor Linkoeping University
Conditions Cardiovascular Diseases
Enrollment 750 participants
Start Date 2022-05-16
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-10